Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention

Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention

Item
http://www.wikidata.org/entity/Q28183625
Q28164422
sameAs
Map-ISODATA demarcates regional response to combination rt-PA and 7E3 F(ab')2 treatment of embolic stroke in the rat.Facilitated thrombolysis: dethrombosis?Functional factor XIII-A is exposed on the stimulated platelet surfaceRecommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention.Facilitated percutaneous coronary intervention in acute myocardial infarction: attractive concept but difficult to prove!Elevating local concentrations of GPIIb-IIIa antagonists counteracts platelet thrombus stability.Intracoronary abciximab use in patients undergoing PCI at a community hospital: a single operator experience.Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.The management of thrombotic lesions in the cardiac catheterization laboratory.Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions.Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.Polyphosphate: physiologic? Pathologic? Pharmacologic?The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots.
P2860

Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention

Item
http://www.wikidata.org/entity/Q28183625
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of Abciximab on the ar ...... primary coronary intervention
@ast
Effects of Abciximab on the ar ...... primary coronary intervention
@en
Effects of Abciximab on the ar ...... primary coronary intervention
@nl
type
label
Effects of Abciximab on the ar ...... primary coronary intervention
@ast
Effects of Abciximab on the ar ...... primary coronary intervention
@en
Effects of Abciximab on the ar ...... primary coronary intervention
@nl
prefLabel
Effects of Abciximab on the ar ...... primary coronary intervention
@ast
Effects of Abciximab on the ar ...... primary coronary intervention
@en
Effects of Abciximab on the ar ...... primary coronary intervention
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Effects of Abciximab on the ar ...... primary coronary intervention
@en
P2093
P304
P31
P356
10.1161/01.CIR.103.19.2328
P407
P433
P478
P50
P577
P698
P921